USPTO serial 79154057
MILTENYI
Reviewed by CopyMark Law Group
Reg. 4838794Status 739Registered
- Filing date
- Status date
- Registration date
- Oct 27, 2015
- Examiner
- GILBERT, REBECCA L
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MILTENYI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bergisch Gladbach, DE
DE
DE
DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; chemical products, namely, chemical additives for use in separation processes for biological materials; chemical, biochemical and diagnostic reagents for cell separation, labelling chemical, biochemical and diagnostic reagents, reagents, cell culture media for growing cells [ , tempering substances and chemical ingredients for the preparation of media, all for non-medical commercial and scientific purposes and for the use in medical research laboratories ] ; [ chemical, biochemical and diagnostic reagents for non-medical purposes for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material; ] chemical, biochemical and diagnostic reagents for non-medical purposes with magnetic beads; antibody reagents other than for medical or veterinary purposes; [ chemical buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments; ] reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes [ ; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; biological tissue culture media, cell culture media, cryogenic chemical preparations for use in the freezing of genetic and blood tissue, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; chemical, biochemical and diagnostic reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry for non-medical purposes ] | ACTIVE | — |
| 005 | Pharmaceutical, medical and veterinary preparations, namely, diagnostic preparations for medical and veterinary use for the purpose of early recognition or characterization of diseases; pharmaceutical and other preparations, namely, diagnostic preparations for medical or veterinary use for the purpose of early recognition or characterization of diseases; reagents, contrast media and diagnostic agents for the preparation of media, all for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, antibody reagents, all for medical or veterinary purposes; disinfectants for medical instruments in the nature of buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media for cultivating and maturing stem cells, tissue cells, immune cells and microorganisms for medical purposes; diagnostic reagents and preparations for medical and veterinary purposes; cryopreservation cell freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, namely, pharmaceutical products for the cellular therapy treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases, immunological, dermatological and neurological diseases; chemical, biological and biochemical products for therapeutic and diagnostic purposes, namely, diagnostic preparations made from chemicals and biochemicals for medical purposes for the treatment of cancer and biological preparations for the therapeutic treatment of cancer, autoimmunity, dermatology, neurological and cardiovascular diseases | ACTIVE | — |
| 009 | Scientific, optical and measuring apparatus and instruments, namely, laboratory apparatus and instruments for the separation, analysis, processing and cultivation of biological material; apparatus for recording, transmission or reproduction of images, data processing equipment, computer software for controlling and managing of blood and blood elements information, computer software for use in operating equipment for the separation, analysis, processing and cultivation of biological material, scientific, electrical and electronic laboratory apparatus and instruments for conducting enzymatic reactions; laboratory equipment, in particular cytometer for measuring physical and/or chemical properties of cells and other particles in suspensions | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments for use in general surgery; apparatus for magnetic cell separation for medical purposes; drainage and transfusion tubing sets for medical purposes; medical diagnostic apparatus in the nature of columns for blood analysis for medical purposes; sacks, bags, sheets, tubes and connectors for surgical, medical, scientific or veterinary purposes, in particular for tissue and blood collection for cryopreservation; surgical apparatus and instruments for medical and surgical purposes; spare parts for the aforesaid goods | ACTIVE | — |
| 042 | Scientific and technological services and research and design services relating hereto, namely, scientific research and design of medical and laboratory equipment; industrial laboratory analysis and research services; design and development of computer hardware and software for the analysis, all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy; medical and pharmaceutical laboratory services for research, analysis and development of new products specifically directed toward manufactured products in the fields of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, kits, reagents, and the selection, stimulation, activation of cells | ACTIVE | — |
| 044 | Medical, pharmaceutical and biotechnological laboratory services relating to the treatment of persons and animals; medical services, in particular the field of extracorporeal plasma therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MILTENYI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 4, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 4, 2026 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Feb 23, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 23, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 28, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Aug 22, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 29, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 29, 2022 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Mar 29, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 20, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 27, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 5, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 25, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 7, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 7, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 27, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 27, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 11, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 5, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 22, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 1, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 18, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 13, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 15, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 15, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 14, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2015 | ALIE | ASSIGNED TO LIE | — |
| May 11, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 28, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 12, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 12, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 8, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 7, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 4, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |